461 related articles for article (PubMed ID: 28251316)
1. Editor's comment on "CRISPR/Cas9-mediated gene editing in human zygotes using Cas9 protein".
Hohmann S
Mol Genet Genomics; 2017 Jun; 292(3):535-536. PubMed ID: 28251316
[No Abstract] [Full Text] [Related]
2. The Combination of CRISPR/Cas9 and iPSC Technologies in the Gene Therapy of Human β-thalassemia in Mice.
Ou Z; Niu X; He W; Chen Y; Song B; Xian Y; Fan D; Tang D; Sun X
Sci Rep; 2016 Sep; 6():32463. PubMed ID: 27581487
[TBL] [Abstract][Full Text] [Related]
3. Gene Therapy and Genome Editing.
Boulad F; Mansilla-Soto J; Cabriolu A; Rivière I; Sadelain M
Hematol Oncol Clin North Am; 2018 Apr; 32(2):329-342. PubMed ID: 29458735
[TBL] [Abstract][Full Text] [Related]
4. A Universal Approach to Correct Various HBB Gene Mutations in Human Stem Cells for Gene Therapy of Beta-Thalassemia and Sickle Cell Disease.
Cai L; Bai H; Mahairaki V; Gao Y; He C; Wen Y; Jin YC; Wang Y; Pan RL; Qasba A; Ye Z; Cheng L
Stem Cells Transl Med; 2018 Jan; 7(1):87-97. PubMed ID: 29164808
[TBL] [Abstract][Full Text] [Related]
5. Gene editing using CRISPR-Cas9 for the treatment of lung cancer.
Castillo A
Colomb Med (Cali); 2016 Dec; 47(4):178-180. PubMed ID: 28293040
[No Abstract] [Full Text] [Related]
6. The tsunami named CRISPR/Cas9.
Chneiweiss H
Rev Neurol (Paris); 2018; 174(7-8):487-488. PubMed ID: 29779853
[No Abstract] [Full Text] [Related]
7. Addressing challenges in the clinical applications associated with CRISPR/Cas9 technology and ethical questions to prevent its misuse.
Kang XJ; Caparas CIN; Soh BS; Fan Y
Protein Cell; 2017 Nov; 8(11):791-795. PubMed ID: 28986765
[No Abstract] [Full Text] [Related]
8. Counterpoint: The Potential Harms of Human Gene Editing Using CRISPR-Cas9.
Baylis F
Clin Chem; 2018 Mar; 64(3):489-491. PubMed ID: 29490999
[No Abstract] [Full Text] [Related]
9. CRISPR/Cas9 β-globin gene targeting in human haematopoietic stem cells.
Dever DP; Bak RO; Reinisch A; Camarena J; Washington G; Nicolas CE; Pavel-Dinu M; Saxena N; Wilkens AB; Mantri S; Uchida N; Hendel A; Narla A; Majeti R; Weinberg KI; Porteus MH
Nature; 2016 Nov; 539(7629):384-389. PubMed ID: 27820943
[TBL] [Abstract][Full Text] [Related]
10. Targeted deletion of BCL11A gene by CRISPR-Cas9 system for fetal hemoglobin reactivation: A promising approach for gene therapy of beta thalassemia disease.
Khosravi MA; Abbasalipour M; Concordet JP; Berg JV; Zeinali S; Arashkia A; Azadmanesh K; Buch T; Karimipoor M
Eur J Pharmacol; 2019 Jul; 854():398-405. PubMed ID: 31039344
[TBL] [Abstract][Full Text] [Related]
11. Efficient gene correction of an aberrant splice site in β-thalassaemia iPSCs by CRISPR/Cas9 and single-strand oligodeoxynucleotides.
Xiong Z; Xie Y; Yang Y; Xue Y; Wang D; Lin S; Chen D; Lu D; He L; Song B; Yang Y; Sun X
J Cell Mol Med; 2019 Dec; 23(12):8046-8057. PubMed ID: 31631510
[TBL] [Abstract][Full Text] [Related]
12. Prime Editing: A Novel Cas9-Reverse Transcriptase Fusion May Revolutionize Genome Editing.
Flotte TR; Gao G
Hum Gene Ther; 2019 Dec; 30(12):1445-1446. PubMed ID: 31860398
[No Abstract] [Full Text] [Related]
13. Correction of IVS I-110(G>A) β-thalassemia by CRISPR/Cas-and TALEN-mediated disruption of aberrant regulatory elements in human hematopoietic stem and progenitor cells.
Patsali P; Turchiano G; Papasavva P; Romito M; Loucari CC; Stephanou C; Christou S; Sitarou M; Mussolino C; Cornu TI; Antoniou MN; Lederer CW; Cathomen T; Kleanthous M
Haematologica; 2019 Nov; 104(11):e497-e501. PubMed ID: 31004018
[No Abstract] [Full Text] [Related]
14. New gene editing technique CRISPR-Cas9 raises important ethical questions, says advisory body.
Hawkes N
BMJ; 2016 Sep; 354():i5318. PubMed ID: 27694221
[No Abstract] [Full Text] [Related]
15. CRISPR/Cas9 gene-editing: Research technologies, clinical applications and ethical considerations.
Memi F; Ntokou A; Papangeli I
Semin Perinatol; 2018 Dec; 42(8):487-500. PubMed ID: 30482590
[TBL] [Abstract][Full Text] [Related]
16. An Exclusive Interview With CRISPR.
McConnell SC
AMA J Ethics; 2019 Dec; 21(12):E1079-1088. PubMed ID: 31876473
[TBL] [Abstract][Full Text] [Related]
17. [CRISPR-Cas system as molecular scissors for gene therapy].
Heinz GA; Mashreghi MF
Z Rheumatol; 2017 Feb; 76(1):46-49. PubMed ID: 28124743
[TBL] [Abstract][Full Text] [Related]
18. CRISPR/Cas9-mediated gene editing in human zygotes using Cas9 protein.
Tang L; Zeng Y; Du H; Gong M; Peng J; Zhang B; Lei M; Zhao F; Wang W; Li X; Liu J
Mol Genet Genomics; 2017 Jun; 292(3):525-533. PubMed ID: 28251317
[TBL] [Abstract][Full Text] [Related]
19. Sharpening the Scissors: Mechanistic Details of CRISPR/Cas9 Improve Functional Understanding and Inspire Future Research.
Raper AT; Stephenson AA; Suo Z
J Am Chem Soc; 2018 Sep; 140(36):11142-11152. PubMed ID: 30160947
[TBL] [Abstract][Full Text] [Related]
20. Gene editing in clinical isolates of Candida parapsilosis using CRISPR/Cas9.
Lombardi L; Turner SA; Zhao F; Butler G
Sci Rep; 2017 Aug; 7(1):8051. PubMed ID: 28808289
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
